• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利益相关者对系统评价中患者参与的看法——德国世界咖啡研讨会的结果。

Stakeholders' perspectives on patient involvement in systematic reviews - Results of a World Café in Germany.

机构信息

Institute for Health Services and Health System Research, Center for Health Services Research, Faculty of Health Sciences Brandenburg, Brandenburg Medical School (Theodor Fontane), Immanuel Klinik Rüdersdorf, Rüdersdorf bei Berlin, Germany.

Institute of Public Health, Faculty of Medicine, University of Cologne, Cologne, Germany.

出版信息

Z Evid Fortbild Qual Gesundhwes. 2024 Aug;188:26-34. doi: 10.1016/j.zefq.2024.06.003. Epub 2024 Jul 22.

DOI:10.1016/j.zefq.2024.06.003
PMID:39043520
Abstract

INTRODUCTION

Patient involvement (PI) in systematic reviews (SRs) can help to improve the quality of SRs and enhance the credibility of the research process. At the same time, PI in SRs poses challenges such as the need for extra time. While several organizations and working groups from English-speaking countries provide recommendations for PI in SRs, there is a lack of current insights from stakeholders in Germany, including researchers and patients. Eliciting their perspectives is indicated, as PI in SRs in Germany might differ due to language barriers and organizational dissimilarities. For sharing and discussing stakeholders' experiences in Germany, a workshop was facilitated. This paper summarizes the results of the workshop to elucidate stakeholders' perspectives on key aspects of PI in SRs in Germany.

METHODS

A World Café was conducted at the 2023 conference of the Network for Evidence-based Medicine. Participants at all levels of experience could take part without prior registration. The data obtained was summarized narratively in an iterative process, and a framework of the topics discussed was developed.

RESULTS

22 participants, predominantly researchers, took part. Participants formulated several general conditions for PI in SRs such as time and transparency. The majority of the tasks described referred to the application phase and the initial phase of a SR. The development of training and information materials in plain German language was deemed essential. The application phase of an externally funded SR and patient recruitment were considered as particularly challenging.

DISCUSSION

Several of the formulated aspects such as time and transparency are consistent with earlier work. The project start of a SR, however, has so far not been explicitly described in the literature as being of particular importance. This phase might be even more crucial to SR projects in Germany since researchers are expected to develop information materials for patients. Both the application phase and patient recruitment could be considered particularly challenging due to a lower degree of organisation of PI in Germany.

CONCLUSION

World Café participants described many aspects referring to the project start of a SR. This underlines that PI in SRs needs to be described as a process. A process model intertwining the phases of a SR with the respective phases of PI, ideally including best practices for each phase, could be of great value. With respect to the specific context in Germany, a greater degree of organization of PI, i.e. coordinated by an institution, could help to manage challenges such as patient recruitment.

摘要

简介

患者参与(PI)系统评价(SRs)可以帮助提高 SRs 的质量,并增强研究过程的可信度。同时,PI 在 SRs 中也带来了一些挑战,例如需要额外的时间。虽然来自英语国家的几个组织和工作组提供了关于 PI 在 SRs 中的建议,但德国的利益相关者(包括研究人员和患者)目前缺乏相关见解。因为 PI 在德国可能由于语言障碍和组织差异而有所不同,所以征求他们的观点是很有必要的。为了分享和讨论德国利益相关者的经验,我们组织了一次研讨会。本文总结了研讨会的结果,阐明了利益相关者对德国 SRs 中 PI 的关键方面的看法。

方法

在 2023 年循证医学网络会议上进行了一次世界咖啡会议。所有经验水平的参与者都可以在没有事先注册的情况下参加。通过迭代过程,对获得的数据进行了叙述性总结,并制定了讨论主题的框架。

结果

22 名参与者,主要是研究人员,参加了会议。参与者提出了 PI 在 SRs 中的一些一般条件,例如时间和透明度。描述的大多数任务都与应用阶段和 SR 的初始阶段有关。制定通俗易懂的德语培训和信息材料被认为是至关重要的。外部资助的 SR 的应用阶段和患者招募被认为是特别具有挑战性的。

讨论

所提出的一些方面,如时间和透明度,与早期的工作是一致的。然而,SR 的项目启动阶段在文献中还没有被明确描述为特别重要。由于研究人员需要为患者开发信息材料,因此该阶段对于德国的 SR 项目可能更为关键。由于德国 PI 的组织程度较低,因此应用阶段和患者招募都可以被认为是特别具有挑战性的。

结论

世界咖啡会议参与者描述了许多与 SR 项目启动相关的方面。这强调了 PI 在 SRs 中需要被描述为一个过程。一个将 SR 阶段与 PI 阶段交织在一起的过程模型,理想情况下包括每个阶段的最佳实践,将具有极大的价值。鉴于德国的具体情况,PI 的更大程度的组织,即由一个机构协调,可以帮助管理患者招募等挑战。

相似文献

1
Stakeholders' perspectives on patient involvement in systematic reviews - Results of a World Café in Germany.利益相关者对系统评价中患者参与的看法——德国世界咖啡研讨会的结果。
Z Evid Fortbild Qual Gesundhwes. 2024 Aug;188:26-34. doi: 10.1016/j.zefq.2024.06.003. Epub 2024 Jul 22.
2
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
3
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
4
Perspectives on systematic review protocol registration: a survey amongst stakeholders in the clinical research publication process.系统评价方案注册的观点:临床研究出版过程中利益相关者的调查。
Syst Rev. 2023 Dec 14;12(1):234. doi: 10.1186/s13643-023-02405-z.
5
[Procedures and methods of benefit assessments for medicines in Germany].[德国药品效益评估的程序和方法]
Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. doi: 10.1055/s-0028-1100954. Epub 2008 Nov 25.
6
The benefits, challenges, and best practice for patient and public involvement in evidence synthesis: A systematic review and thematic synthesis.患者和公众参与证据综合的益处、挑战和最佳实践:系统评价和主题综合。
Health Expect. 2023 Aug;26(4):1436-1452. doi: 10.1111/hex.13787. Epub 2023 Jun 1.
7
The Nordic Nutrition Recommendations 2022 - prioritisation of topics for systematic reviews.《2022年北欧营养建议——系统评价主题的优先排序》
Food Nutr Res. 2021 Oct 8;65. doi: 10.29219/fnr.v65.7828. eCollection 2021.
8
Guidance on how to efficiently find, choose, and use available systematic reviews was developed.制定了如何高效查找、选择和使用现有系统评价的指南。
J Clin Epidemiol. 2024 Sep;173:111466. doi: 10.1016/j.jclinepi.2024.111466. Epub 2024 Jul 15.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Patient involvement in a systematic review: Development and pilot evaluation of a patient workshop.患者参与系统评价:患者研讨会的开发与初步评估
Z Evid Fortbild Qual Gesundhwes. 2017 Nov;127-128:56-61. doi: 10.1016/j.zefq.2017.07.005. Epub 2017 Nov 10.

引用本文的文献

1
Lessons learned from the participatory development of a framework to actively involve people living with dementia, individuals from their social networks, and healthcare professionals in systematic reviews: the DECIDE-SR study.从一个框架的参与式开发中吸取的经验教训:该框架旨在让痴呆症患者、其社交网络中的个人以及医疗保健专业人员积极参与系统评价,即DECIDE-SR研究。
Res Involv Engagem. 2025 Apr 30;11(1):39. doi: 10.1186/s40900-025-00719-x.